Silence Therapeutics EPS Diluted (Quarterly) Insights

Silence Therapeutics PLC (SLN)

13.98 -1.30 (-8.54%) USD | NASDAQ | Nov 14, 16:00

13.98 0.00 (0.00%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	-0.4201
March 31, 2024	-0.0533
December 31, 2023	-0.4657
September 30, 2023	-0.2811
June 30, 2023	-0.3605
March 31, 2023	-0.3464
December 31, 2022	-0.4621
September 30, 2022	-0.2542

Date	Value
June 30, 2022	-0.5016
March 31, 2022	-0.3462
December 31, 2021	-0.4246
September 30, 2021	-0.4591
June 30, 2021	-0.5493
March 31, 2021	-0.4011
December 31, 2020	-0.5977
September 30, 2020	-0.4264

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.5977

Minimum

Dec 2020

-0.0533

Maximum

Mar 2024

-0.3969

Average

-0.4224

Median

EPS Diluted (Quarterly) Benchmarks

NuCana PLC	-3.785
TC BioPharm (Holdings) PLC	-27.90
Biodexa Pharmaceuticals PLC	--
Adaptimmune Therapeutics PLC	0.24
Verona Pharma PLC	-0.56

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-19.63M
Revenue (Quarterly)	0.7545M
Total Expenses (Quarterly)	23.87M
Enterprise Value	525.86M
Gross Profit Margin (Quarterly)	-341.1%
Profit Margin (Quarterly)	-2.60K%
Earnings Yield	-8.73%
Normalized Earnings Yield	-8.732